DNX FORCED TO CURTAIL BLOOD SUBSTITUTE STUDIES

DNX FORCED TO CURTAIL BLOOD SUBSTITUTE STUDIES

DNX Corp. said this week that cash problems were forcing it to curtail revolutionary research into a